Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
The Annals of Pharmacotherapy|February 24, 2001
Idiopathic pneumonia syndrome following myeloablative chemotherapy and autologous transplantationS F Bilgrami, M L Metersky, D McNally, et al.
American Journal of Human Genetics|March 1, 1996
FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicingG A Meyers, D Day, R Goldberg, et al.
American Journal of Human Genetics|June 19, 1998
Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutationsW A Paznekas, M L Cunningham, T D Howard, et al.
The Johns Hopkins Medical Journal|October 1, 1975
Mucolipidosis III (pseudo-Hurler polydystrophy): Clinical and laboratory studies in a series of 12 patientsT E Kelly, G H Thomas, H A Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2019
A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin LymphomaBrad S Kahl, Mehdi Hamadani, John Radford, et al.
American Journal of Human Genetics|June 7, 2000
Novel HOXA13 mutations and the phenotypic spectrum of hand-foot-genital syndromeF R Goodman, C Bacchelli, A F Brady, et al.
Leukemia Research|June 11, 2020
Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I studyAaron D Goldberg, Ehab Atallah, David Rizzieri, et al.
Blood|November 19, 2020
Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphomaMehdi Hamadani, John Radford, Carmelo Carlo-Stella, et al.
Nature Communications|September 1, 2025
Coagulation factor XII haploinsufficiency is protective against venous thromboembolism in a population-scale multidimensional analysisAmelia K Haj, David S Paul, Sean J Jurgens, et al.
The New England Journal of Medicine|May 8, 2024
Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic PurpuraPavan K Bendapudi, Brody H Foy, Sarah B Mueller, et al.
Pageof 13